Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Godavari Drugs Ltd. Share Price
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹125.18 |
|---|---|
| Day's Range | ₹111.50 - ₹130.90 |
| Open | ₹111.50 |
| 52 Week Range | ₹69.70 - ₹135.25 |
| Volume | 55,906 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 69.27 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 32.87 |
| TTM EPS (₹) | 3.81 |
| P/E Ratio | 15.04 |
| Book Value(₹) | 1.74 |
| PAT Margin (%) | 3.86 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 10.13 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 238.11 | 1133.5 |
| Expenses | N/A | N/A |
| PBT | 13.03 | 56.25 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 10.41 | 43.8 |
About Godavari Drugs Ltd.
| Founded | 1987 |
|---|---|
| Managing Director | Mukund Kakani |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,44,716.74 | 1,853.50 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,55,115.31 | 9,610.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,89,613.38 | 4,985.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,27,823.12 | 8,889.90 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,19,899.96 | 1,202.00 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,18,325.00 | 682.80 | 0.00 - 0.00 |
| Cipla Ltd. | 1,12,875.68 | 1,397.20 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,08,116.47 | 2,001.00 | 823.10 - 823.10 |
| Mankind Pharma Ltd. | 1,02,247.25 | 2,460.00 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,00,395.34 | 1,202.80 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Godavari Drugs informs about closure of trading window
In terms of the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons framed pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, Godavari Drugs has informed that the trading window for dealing in the securities of the Company by the Designated persons and their immediate relatives will be closed with effect from Thursday, 01st October, 2026 till 48 hours after declaration of unaudited Financial Results of the Company for the Half Year ended 30th September, 2026. The date of the Board meeting of the Company for consideration and approval of unaudited Financial Results for the Half Year ended 30th September, 2026 shall be intimated in due course. The Designated persons and their immediate relatives shall not trade in the securities of the Company when the trading window is closed.
Godavari Drugs informs about press release
Godavari Drugs informs about statement on deviation
Godavari Drugs submits newspaper advertisement
Hindustan Bio Sciences informs about closure of trading window
Hindustan Bio Sciences has informed that the Trading window for dealing in the securities of the company will remain closed from 1st October 2026 till 48 hours after the announcement of standalone Un-audited Financial results for the quarter ending on September 30th 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Godavari Drugs Ltd. is ₹125.18 as of 2026-09-25.
The market capitalisation of Godavari Drugs Ltd. is ₹136.62 as of 2026-09-25.
The 1-year return of Godavari Drugs Ltd. is 38.67% as of 2026-09-25.
The P/E ratio of Godavari Drugs Ltd. is 15.04 as of 2026-09-28.
The 52-week high and low of Godavari Drugs Ltd. are ₹135.25 and ₹69.70, respectively, as of 2026-09-25.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
